ArticleFrontiers in immunology2026

Acquired resistance to first-line immune checkpoint inhibitors in esophageal squamous cell carcinoma: progression patterns and prognostic implications.

Rui-Ying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.